CA2516291A1 - Forme de dosage presentant une matrice en saccharide - Google Patents
Forme de dosage presentant une matrice en saccharide Download PDFInfo
- Publication number
- CA2516291A1 CA2516291A1 CA002516291A CA2516291A CA2516291A1 CA 2516291 A1 CA2516291 A1 CA 2516291A1 CA 002516291 A CA002516291 A CA 002516291A CA 2516291 A CA2516291 A CA 2516291A CA 2516291 A1 CA2516291 A1 CA 2516291A1
- Authority
- CA
- Canada
- Prior art keywords
- dosage form
- allergen
- form according
- solid dosage
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300318 | 2003-02-28 | ||
DKPA200300318 | 2003-02-28 | ||
US46538303P | 2003-04-25 | 2003-04-25 | |
US60/465,383 | 2003-04-25 | ||
PCT/DK2004/000119 WO2004075875A1 (fr) | 2003-02-28 | 2004-02-24 | Forme de dosage presentant une matrice en saccharide |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2516291A1 true CA2516291A1 (fr) | 2004-09-10 |
CA2516291C CA2516291C (fr) | 2012-02-14 |
Family
ID=32929063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2516291A Expired - Fee Related CA2516291C (fr) | 2003-02-28 | 2004-02-24 | Forme de dosage presentant une matrice en saccharide |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1599185A1 (fr) |
JP (1) | JP4688787B2 (fr) |
KR (1) | KR101136573B1 (fr) |
AU (1) | AU2004216559B2 (fr) |
CA (1) | CA2516291C (fr) |
HK (1) | HK1089083A1 (fr) |
MX (1) | MXPA05009079A (fr) |
PL (1) | PL210707B1 (fr) |
WO (1) | WO2004075875A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9731018B2 (en) | 2011-09-16 | 2017-08-15 | Ferring B.V. | Fast dissolving pharmaceutical composition |
US10023335B2 (en) | 2010-03-29 | 2018-07-17 | Ferring B.V. | Fast dissolving pharmaceutical composition |
US10086078B2 (en) | 2010-03-29 | 2018-10-02 | Ferring B.V. | Fast dissolving pharmaceutical composition |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060210590A1 (en) | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
AU2006299310A1 (en) | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
PL2493457T3 (pl) | 2009-10-30 | 2018-01-31 | Ix Biopharma Ltd | Szybko rozpuszczalna stała postać dawkowana |
JP5800527B2 (ja) * | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法 |
MY164204A (en) * | 2010-11-04 | 2017-11-30 | Norgine Bv | Formulations comprising polyethylene glycol |
JP2012240975A (ja) * | 2011-05-20 | 2012-12-10 | Nitto Denko Corp | 医薬組成物及びゼリー状製剤 |
JP2012240978A (ja) * | 2011-05-20 | 2012-12-10 | Nitto Denko Corp | 医薬組成物及びゼリー状製剤 |
ES2940686T3 (es) * | 2013-03-14 | 2023-05-10 | Nestle Sa | Fabricación de formulaciones de cacahuete para la desensibilización oral |
EP2952200A1 (fr) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergène pour le traitement prophylactique d'une allergie |
GB2545880A (en) | 2015-10-20 | 2017-07-05 | Glide Pharmaceutical Tech Ltd | Solid formulation |
CN111432804A (zh) * | 2017-11-27 | 2020-07-17 | 帝斯曼知识产权资产管理有限公司 | 冻干的多微粒固体剂型 |
JP6592791B1 (ja) * | 2018-01-29 | 2019-10-23 | 株式会社リタファーマ | 医薬製剤及びその製造方法 |
CN113966229A (zh) | 2019-05-10 | 2022-01-21 | 爱沐疗法公司 | 用于改善花生过敏患者的生活质量的方法 |
CN116891827B (zh) * | 2023-09-08 | 2024-01-30 | 山东康华生物医疗科技股份有限公司 | 一种nk细胞活性激活体系 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD107208A1 (fr) | 1973-06-04 | 1974-07-20 | ||
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
FR2609895B1 (fr) | 1987-01-28 | 1991-06-28 | Bruttmann Georges | Nouvelles formes galeniques d'allergenes pour administration par voie per- et sub-linguale |
US5558880A (en) | 1989-12-22 | 1996-09-24 | Janssen Pharmaceutica Inc. | Pharmaceutical and other dosage forms |
US5215756A (en) | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
US6337082B1 (en) | 1991-10-25 | 2002-01-08 | Biovail Tech Ltd | Saccharide-based matrix |
US5343762A (en) | 1992-10-05 | 1994-09-06 | Rosemount Inc. | Vortex flowmeter |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
BR9405996A (pt) * | 1993-03-11 | 1995-12-19 | Secretech Inc | Mucoadesivos poliméricos na distribuição de imunógenos em superfícies mucosais |
US6010719A (en) * | 1997-09-16 | 2000-01-04 | Universiteit Gent | Freeze-dried disintegrating tablets |
GB9722682D0 (en) * | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
US20020197321A1 (en) | 1997-10-27 | 2002-12-26 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
KR20010041918A (ko) | 1998-03-16 | 2001-05-25 | 알크-아벨로 에이/에스 | 돌연변이 재조합체 알러젠 |
GB9901819D0 (en) * | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
FR2791569B1 (fr) * | 1999-03-31 | 2003-05-09 | Pf Medicament | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention |
US20060073188A1 (en) * | 1999-03-31 | 2006-04-06 | Pierre Fabre Medicament | Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
ES2605109T3 (es) * | 1999-08-24 | 2017-03-13 | Abic Biological Laboratories Ltd. | Composición de vacuna y procedimiento de uso de la misma |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
DE19951970A1 (de) * | 1999-10-28 | 2001-05-03 | Bionetworks Gmbh | Arzneimittel für die Toleranzinduktion |
GB0020089D0 (en) | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
DE60136653D1 (de) | 2000-11-16 | 2009-01-02 | Alk Abello As | Mutante allergene |
US6733781B2 (en) * | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
ITMI20010571A1 (it) * | 2001-03-19 | 2002-09-19 | Grisotech S A | Vaccini assorbibili per via trans-mucosale |
PL212139B1 (pl) | 2002-05-16 | 2012-08-31 | Alk Abello As | Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja zawierająca dwa lub więcej wariantów zrekombinowanych zmutowanych alergenów, zastosowanie takiej kompozycji, kompozycja farmaceutyczna zawierająca zrekombinowany alergen lub wymienioną kompozycję, zastosowanie zrekombinowanego alergenu, kompozycji lub kompozycji farmaceutycznej, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sposób przygotowania biblioteki zrekombinowanego alergenu, sekwencja DNA kodująca zrekombinowany alergen, wektor ekspresyjny obejmujący wymienione DNA, komórka gospodarza zawierająca taki wektor ekspresyjny, sposób produkcji zrekombinowanego mutanta alergenu, oraz oznaczenie diagnostyczne do oceny odpowiedniości, bezpieczeństwa lub wyniku terapii |
-
2004
- 2004-02-24 MX MXPA05009079A patent/MXPA05009079A/es active IP Right Grant
- 2004-02-24 JP JP2006501528A patent/JP4688787B2/ja not_active Expired - Fee Related
- 2004-02-24 AU AU2004216559A patent/AU2004216559B2/en not_active Ceased
- 2004-02-24 EP EP04713847A patent/EP1599185A1/fr not_active Withdrawn
- 2004-02-24 WO PCT/DK2004/000119 patent/WO2004075875A1/fr active Search and Examination
- 2004-02-24 KR KR1020057015834A patent/KR101136573B1/ko not_active IP Right Cessation
- 2004-02-24 CA CA2516291A patent/CA2516291C/fr not_active Expired - Fee Related
- 2004-02-24 PL PL378543A patent/PL210707B1/pl unknown
-
2006
- 2006-08-25 HK HK06109448.3A patent/HK1089083A1/xx not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10023335B2 (en) | 2010-03-29 | 2018-07-17 | Ferring B.V. | Fast dissolving pharmaceutical composition |
US10086078B2 (en) | 2010-03-29 | 2018-10-02 | Ferring B.V. | Fast dissolving pharmaceutical composition |
US9731018B2 (en) | 2011-09-16 | 2017-08-15 | Ferring B.V. | Fast dissolving pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
MXPA05009079A (es) | 2006-05-19 |
KR101136573B1 (ko) | 2012-04-23 |
PL210707B1 (pl) | 2012-02-29 |
WO2004075875A1 (fr) | 2004-09-10 |
HK1089083A1 (en) | 2006-11-24 |
KR20050105491A (ko) | 2005-11-04 |
AU2004216559B2 (en) | 2010-05-27 |
PL378543A1 (pl) | 2006-05-02 |
JP2006519187A (ja) | 2006-08-24 |
WO2004075875A8 (fr) | 2004-12-29 |
AU2004216559A1 (en) | 2004-09-10 |
CA2516291C (fr) | 2012-02-14 |
EP1599185A1 (fr) | 2005-11-30 |
JP4688787B2 (ja) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2516291A1 (fr) | Forme de dosage presentant une matrice en saccharide | |
KR101281147B1 (ko) | 알레르겐 제형 | |
ES2266820T4 (es) | Desmopresina en una forma de dosificación orodispersable | |
AU2002237548B2 (en) | Intraorally rapidly disintegrable tablet | |
KR100655627B1 (ko) | 구강 내에서 급속히 붕괴되는 정제 | |
US8012505B2 (en) | Dosage form having a saccharide matrix | |
EP1236466B1 (fr) | Compositions auto-adhésives solides pour le traitement topique des troubles de la muqueuse orale | |
RU2189227C2 (ru) | Быстро распадающиеся прессованные в формах материалы и способ их получения | |
JP2006513269A5 (fr) | ||
JP2006519187A5 (fr) | ||
US20120135076A1 (en) | Intrabuccally rapidly disintegrating tablet and a production method of the tablets | |
US20090155351A1 (en) | Solid Vaccine Formulation | |
PL187160B1 (pl) | Sposób wytwarzania rozpuszczalnej wewnątrzustnie formowanej tłocznie wypraski | |
JP2003534270A (ja) | 速放錠及びその製造方法 | |
RU2273472C2 (ru) | Лекарственный состав, быстро распадающийся в ротовой полости, и способ его изготовления | |
JPH0948726A (ja) | 口腔内速崩壊性製剤およびその製法 | |
CA2720455A1 (fr) | Immunotherapie specifique d'un allergene mucosomal avec dosage initial apres le debut de la saison du pollen | |
BRPI0616879A2 (pt) | formulação de vacina sólida | |
US20210346295A1 (en) | Flowpack for oral delivery of active ingredients | |
RU2005120017A (ru) | Лекарственная форма, содержащая аллерген | |
Jangid et al. | DISPERSIBLE TABLET AS A FORMULATION FOR ORAL DRUG DELIVERY SYSTEM | |
RU2432171C2 (ru) | Иммуностимулирующее лекарственное средство и способ его получения | |
CN118103029A (zh) | 具有改善的口感的右旋糖片剂 | |
KR20040046575A (ko) | 신속 붕해 및 용해용 정제 과립제 산제의 조성물 및 그제조방법 | |
Solan | INTERNATIONALE PHARMACEUTICA SCIENCIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20170224 |